SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,101,000 | -60.6% | 14,770 | -9.8% | 0.11% | -62.1% |
| Q4 2020 | $2,792,000 | +11.2% | 16,375 | -8.4% | 0.28% | +0.7% |
| Q3 2020 | $2,510,000 | -13.9% | 17,875 | -1.7% | 0.28% | -21.6% |
| Q2 2020 | $2,914,000 | +63.9% | 18,175 | 0.0% | 0.36% | +35.7% |
| Q1 2020 | $1,778,000 | +5.8% | 18,175 | +39.5% | 0.26% | +34.2% |
| Q4 2019 | $1,681,000 | +50.4% | 13,030 | +0.9% | 0.20% | +37.1% |
| Q3 2019 | $1,118,000 | -4.7% | 12,920 | +67.4% | 0.14% | -5.9% |
| Q2 2019 | $1,173,000 | +51.0% | 7,720 | +18.4% | 0.15% | +49.0% |
| Q1 2019 | $777,000 | +154.8% | 6,520 | +147.9% | 0.10% | +137.2% |
| Q4 2018 | $305,000 | – | 2,630 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |